Innate Pharma SA (FR:IPH) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Innate Pharma SA has unveiled its 2025 financial calendar, with key dates for the release of its financial statements and shareholders meeting. Investors can expect updates on March 27, May 13, September 17, and November 13, as the company continues to advance its innovative cancer immunotherapies. Innate Pharma, listed on Euronext Paris and Nasdaq, partners with major biopharmaceutical firms like Sanofi and AstraZeneca.
For further insights into FR:IPH stock, check out TipRanks’ Stock Analysis page.
